Shannon L. Harris

Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease

Han-Qing Jiang, Susan K. Hoiseth, Shannon L. Harris et al. · Vaccine · 2010 · 199 citations

Veterinary Medicine, Immunology, Infectious Diseases +16

Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trial

Peter Richmond, Helen Marshall, Michael D. Nissen et al. · The Lancet Infectious Diseases · 2012 · 131 citations · Full text

Veterinary Medicine, Infectious Diseases, Pediatrics +12

Exploring the basis of peptide–carbohydrate crossreactivity: Evidence for discrimination by peptides between closely related anti-carbohydrate antibodies

Shannon L. Harris, Lisa Craig, Jarnail S. Mehroke et al. · Proceedings of the National Academy of Sciences · 1997 · 121 citations

Life Sciences, Biochemistry, Immunology +17

A phase 2 open-label safety and immunogenicity study of a meningococcal B bivalent rLP2086 vaccine in healthy adults

Helen Marshall, Peter Richmond, Michael D. Nissen et al. · Vaccine · 2013 · 81 citations

Veterinary Medicine, Immunology, Infectious Diseases +17

A Bivalent Meningococcal B Vaccine in Adolescents and Young Adults

Lars Østergaard, Timo Vesikari, Judith Absalon et al. · New England Journal of Medicine · 2017 · 72 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17